A new drug which may one day pre-vent the dreaded Human Immunodeficiency Virus (HIV) has been dis-covered. Already approved for the treatment of HIV and rec-ommended on Thursday by the United States’ Food and Drug Administration advi-sory committee, the drug, Truvuda, is to be approved for pre-exposure prophy-laxis. It is an experimental strategy which forestalls the contraction of HIV. Manufactured by a US based firm; Gilead Scienc-es, Incorporation, the once-a-day pill used in combina-tion with other HIV drugs does not rid the body of HIV, rather, prevents the vi-rus from replicating in the body.
No comments:
Post a Comment